Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration to Advance Innovative Immunotherapies
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets […]
Sequanta and Mission Bio Announce Strategic Partnership
Sequanta Technologies Co., Ltd. and Mission Bio are pleased to announce that they have entered […]
Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today […]
Robocath and Rennes University Hospital Launch Co-development Research Program into Treatment of Strokes in Partnership with Philips France
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and […]
Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has […]
Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs
Otsuka Pharmaceutical Development & Commercialization, Inc. (“Otsuka”), announces today that it has entered a three-year […]
Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration
Sosei Group Corporation (“the Company”) (TSE: 4565), the world leader in GPCR-focused structure-based drug design and […]
AI Software Which Helps Diagnose Lung Cancer Receives Gov Funding Boost
New AI software to help better diagnose lung cancer has received major government funding. Lung […]
Olive Hits a $4 Billion Valuation with $400 Million of Capital Led by Vista Equity Partners
Olive, the automation company creating the Internet of Healthcare, announced today it closed a $400 million funding […]
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Transine Therapeutics, a biotechnology company developing a novel class of therapeutic RNAs based on its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more